| Convergent antibody responses to SARS-CoV-2 in convalescent individuals DF Robbiani, C Gaebler, F Muecksch, JCC Lorenzi, Z Wang, A Cho, ... Nature 584 (7821), 437-442, 2020 | 2104 | 2020 |
| Evolution of antibody immunity to SARS-CoV-2 C Gaebler, Z Wang, JCC Lorenzi, F Muecksch, S Finkin, M Tokuyama, ... Nature 591 (7851), 639-644, 2021 | 1810 | 2021 |
| mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants Z Wang, F Schmidt, Y Weisblum, F Muecksch, CO Barnes, S Finkin, ... Nature 592 (7855), 616-622, 2021 | 1540 | 2021 |
| Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants Y Weisblum, F Schmidt, F Zhang, J DaSilva, D Poston, JCC Lorenzi, ... elife 9, e61312, 2020 | 1532 | 2020 |
| Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies CO Barnes, AP West, KE Huey-Tubman, MAG Hoffmann, NG Sharaf, ... Cell 182 (4), 828-842. e16, 2020 | 811 | 2020 |
| Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection Z Wang, F Muecksch, D Schaefer-Babajew, S Finkin, C Viant, C Gaebler, ... Nature 595 (7867), 426-431, 2021 | 789 | 2021 |
| Vaccine breakthrough infections with SARS-CoV-2 variants E Hacisuleyman, C Hale, Y Saito, NE Blachere, M Bergh, EG Conlon, ... New England Journal of Medicine 384 (23), 2212-2218, 2021 | 788 | 2021 |
| Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization F Klein, R Diskin, JF Scheid, C Gaebler, H Mouquet, IS Georgiev, ... Cell 153 (1), 126-138, 2013 | 658 | 2013 |
| Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses F Schmidt, Y Weisblum, F Muecksch, HH Hoffmann, E Michailidis, ... Journal of Experimental Medicine 217 (11), 2020 | 598 | 2020 |
| HIV therapy by a combination of broadly neutralizing antibodies in humanized mice F Klein, A Halper-Stromberg, JA Horwitz, H Gruell, JF Scheid, ... Nature 492 (7427), 118-122, 2012 | 596 | 2012 |
| Plasma neutralization of the SARS-CoV-2 Omicron variant F Schmidt, F Muecksch, Y Weisblum, J Da Silva, E Bednarski, A Cho, ... New England Journal of Medicine 386 (6), 599-601, 2022 | 476 | 2022 |
| Enhanced SARS-CoV-2 neutralization by dimeric IgA Z Wang, JCC Lorenzi, F Muecksch, S Finkin, C Viant, C Gaebler, ... Science translational medicine 13 (577), eabf1555, 2021 | 471 | 2021 |
| Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies AJ Greaney, TN Starr, CO Barnes, Y Weisblum, F Schmidt, M Caskey, ... Nature communications 12 (1), 4196, 2021 | 388 | 2021 |
| Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination A Cho, F Muecksch, D Schaefer-Babajew, Z Wang, S Finkin, C Gaebler, ... Nature 600 (7889), 517-522, 2021 | 286 | 2021 |
| Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations F Muecksch, Y Weisblum, CO Barnes, F Schmidt, D Schaefer-Babajew, ... Immunity 54 (8), 1853-1868. e7, 2021 | 268 | 2021 |
| Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost F Muecksch, Z Wang, A Cho, C Gaebler, T Ben Tanfous, J DaSilva, ... Nature 607 (7917), 128-134, 2022 | 264 | 2022 |
| High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape F Schmidt, Y Weisblum, M Rutkowska, D Poston, J DaSilva, F Zhang, ... Nature 600 (7889), 512-516, 2021 | 220 | 2021 |
| Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein F Klein, C Gaebler, H Mouquet, DN Sather, C Lehmann, JF Scheid, Z Kraft, ... Journal of Experimental Medicine 209 (8), 1469-1479, 2012 | 195 | 2012 |
| Persistent cellular immunity to SARS-CoV-2 infection G Breton, P Mendoza, T Hägglöf, TY Oliveira, D Schaefer-Babajew, ... Journal of Experimental Medicine 218 (4), e20202515, 2021 | 149 | 2021 |
| Prolonged viral suppression with anti-HIV-1 antibody therapy C Gaebler, L Nogueira, E Stoffel, TY Oliveira, G Breton, KG Millard, ... Nature 606 (7913), 368-374, 2022 | 128 | 2022 |
